Forget Ozempic: Strong Bullish Pharma Co. Targets $7 Trillion Mega Trend
Weight loss drugs are the other story of 2023. But as I sat around the Thanksgiving table with family last week and noticed that no one seemed to be eating less, I couldn’t help but think about a different health care mega trend…
Read More